Staff Directory

Academic Qualification
- PhD in Pharmacology (Drug Development) - Doctor of Philosophy, Universiti Sains Malaysia (USM)
- Master of Science (Pharmacology) - Masters Degree, Universiti Sains Malaysia (USM)
- Doctor of Medicine - Bachelor Degree, Universiti Sains Malaysia (USM)
Abdul Razak Kasmuri (Assoc. Prof. Dr.)
Associate Professor
IIUM Kuantan Campus
KULLIYYAH OF PHARMACY
drazak@iium.edu.my
4871
Expert Profile
Abdul Razak Bin Kasmuri obtained his MD and MSc (Pharmacology) degrees from School of Medical Sciences USM and PhD degree from School of Pharmaceutical Sciences USM Penang. Upon completion of his PhD he joined Kulliyyah of Pharmacy, IIUM. He was a Deputy Dean of Postgraduate and Research in 2006/2007 and Deputy Dean of Student Affairs in 2008/2009 at Kulliyyah pharmacy. He chaired a committee in drafting the IIUM Animal Ethics Policy in 2009 and the policy was endorsed by university senate in 2012. He was a committee member of Malaysian Society of Pharmacology and Physiology (MSPP) for 2007/2008, 2008/2009 and 2011/2012 sessions.
Presently Dr Abdul Razak is an Associate Professor at the Department of Basic of Medical Sciences of Kulliyyah of Pharmacy IIUM.
Presently Dr Abdul Razak is an Associate Professor at the Department of Basic of Medical Sciences of Kulliyyah of Pharmacy IIUM.
Area of Specialisation
- Medical And Health ~ Medical And Health Sciences ~ Pharmacy ~ Drug Discovery - Characterization and separation of active compounds of screened antidiabetic herbs
- Medical And Health ~ Medical And Health Sciences ~ Pharmacology ~ Other Pharmacology n.e.c. - Development of pharmacological models in screening antidiabetics herbs.
- Medical And Health ~ Medical And Health Sciences ~ Pharmacology ~ Clinical Pharmacology - Study the mode of action of medicinal herbs
- Biotechnology ~ Biotechnology ~ Animal Biotechnology ~ Cell Line Culture - Utilizing cell line in screening antidiabetics herbs
- Natural Science ~ Mathematical Sciences ~ Mathematics and Statistics for Science and Engineering ~ Biological and Medical Sciences - Utilizing diabetic animal models in studying effect of antidiabetics herbs
Teaching Responsibilities
ANTI CANCER CHEMOTHERAPY | 2020/2021 2019/2020 2018/2019 2017/2018 2015/2016 2014/2015 2013/2014 2012/2013 |
ANTI-INFECTIVE & CYTOTOXIC AGENTS | 2013/2014 2012/2013 2011/2012 2010/2011 2009/2010 |
ANTI-INFECTIVE AGENTS | 2022/2023 2021/2022 2020/2021 |
ANTI-INFECTIVES AGENTS | 2021/2022 2020/2021 2018/2019 2017/2018 2016/2017 2014/2015 2013/2014 2012/2013 2011/2012 |
ANTICANCER CHEMOTHERAPY | 2022/2023 2021/2022 |
Antiinfective and Cytotoxic Agents | 2008/2009 |
BODY SYSTEM & THERAPEUTICS I : CARDIOVASCULAR & HAEMATOLOGY | 2021/2022 2020/2021 |
BODY SYSTEM & THERAPEUTICS II : RESPIRATORY & URINARY SYSTEM | 2021/2022 2020/2021 |
BODY SYSTEM & THERAPEUTICS III: MSK SYSTEM & SENSORY ORGANS | 2022/2023 2021/2022 |
BODY SYSTEM & THERAPEUTICS IV: GIT & HEPATOBILIARY SYSTEMS | 2022/2023 2021/2022 |
BODY SYSTEM & THERAPEUTICS VI : CENTRAL NERVOUS SYSTEM | 2021/2022 |
BODY SYSTEM I : CARDIOVACULAR & HAEMATOLOGY | 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 2014/2015 2013/2014 2012/2013 |
BODY SYSTEM II : RESPIRATORY & URINARY SYSTEM | 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 |
BODY SYSTEM III : MUSCULOSKELETAL & SENSORY ORGANS | 2019/2020 2017/2018 2016/2017 2014/2015 2013/2014 2012/2013 2011/2012 |
Body System IV : Musculo-skeletal | 2011/2012 2010/2011 |
BODY SYSTEM IV: GASTROINTESTINAL &HEPATOBILIARY SYSTEMS | 2020/2021 2019/2020 2018/2019 2017/2018 |
BODY SYSTEM V : ENDOCRINE & REPRODUCTIVE SYSTEMS | 2020/2021 2019/2020 2018/2019 2017/2018 2015/2016 2014/2015 2013/2014 2012/2013 |
BODY SYSTEM VI : CNS | 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 2014/2015 2013/2014 2012/2013 |
BODY SYSTEM VII : CENTRAL NERVOUS SYSTEM | 2011/2012 2010/2011 2009/2010 |
BODY SYSTEM VIII : SENSORY ORGAN | 2013/2014 2012/2013 2011/2012 2010/2011 2009/2010 |
Body System VIII : Sensory Organs | 2008/2009 2007/2008 2006/2007 |
Clinical Pharmacy II | 2009/2010 |
CLINICAL TOXICOLOGY | 2022/2023 2021/2022 2020/2021 2019/2020 2018/2019 2016/2017 2015/2016 2014/2015 2013/2014 2012/2013 |
Drug Delivery System | 2010/2011 |
FAMILY MANAGEMENT | 2022/2023 2021/2022 2020/2021 |
FAMILY MANAGEMENT AND PARENTING | 2019/2020 2018/2019 2017/2018 2016/2017 2015/2016 2014/2015 2013/2014 2012/2013 |
FINAL YEAR RESEARCH PROJECT | 2022/2023 |
FUNDAMENTALS OF PHARMACOLOGY | 2017/2018 2016/2017 2015/2016 2013/2014 2012/2013 2011/2012 2010/2011 |
FUNDAMENTALS OF PHYSIOLOGY | 2013/2014 2012/2013 2011/2012 2010/2011 |
HALAQAH 1 | 2007/2008 |
HALAQAH 2 | 2007/2008 2006/2007 |
ISLAMIC INPUT IN PHARMACY | 2022/2023 2017/2018 2016/2017 2015/2016 2013/2014 2012/2013 2011/2012 2010/2011 |
OTC (over the counter) Medication | 2011/2012 |
Pharmacokinetics and Biopharmaceutics | 2007/2008 2006/2007 |
PHARMACOLOGY OF PERIPHERAL NERVOUS SYSTEM | 2020/2021 |
PHARMACOLOGY OF THE PERIPHERAL NERVOUS SYSTEM | 2018/2019 2017/2018 2016/2017 2015/2016 2014/2015 2013/2014 2012/2013 2011/2012 2010/2011 |
Pharmacotherapeutics II | 2009/2010 |
Problem-based Learning I | 2006/2007 |
Problem-based Learning II | 2006/2007 |
STUDY CIRCLE 1 | 2011/2012 |
STUDY CIRCLE 2 | 2011/2012 2010/2011 |
STUDY CIRCLE 2 (BROTHER) | 2013/2014 2012/2013 |
Research Projects
Completed
2016 - 2018 | ??Glucosidase Inhibitor and Aroma from the Flesh of Salak (Salacca zalacca) Fruit, their Metabolic Demarcation and Antidiabetic Potential |
2016 - 2019 | Incorporation of stingless bee honey into hydrogel as a potential wound healing promoter |
2016 - 2019 | Influence of multiple reaction monitoring (MRM) on the separation of amlodipine and perindopril in pharmaceutical dosage form and plasma |
2015 - 2020 | Addressing Formulation Issues of Syariah Compliant Generic Sustained Release Antidiabetic Solid Dosage Form |
2015 - 2019 | Isolation Of ?-Glucosidase Inhibitor and aroma from the Flesh of Salak (Salacca zalacca) Fruit and Their Metabolic Profiling on GC/MS. |
2015 - 2019 | The Effects of the Antioxidant Active Fractions of Ficus Deltoidea on Fatty Acid Induced-Insulin Resistance Cells Model as a Potential Therapeutic Agent for Types 2 Diabetes Mellitus |
2014 - 2018 | In Vitro Anticancer Potentials Of Ethyl P-Methoxycinnamate (EPMC) An Active Ingredient Of Cekur (Kaempferia Galanga) On Human Cancer Cell Lines Differing In P53 Status. |
2014 - 2018 | Synthesis and Mechanistic Evaluation of Orvinol Analogues as Potential Anti-Relapse to Morphine/ Methamphetamine Dependence |
2014 - 2017 | Estimation of Amlodipne Level in Diabetic and Hypertensive Rats' Urine and its Effects on Adrenergic Receptors |
2013 - 2018 | Nano-Transfersomes as a Novel Elastic Transdermal Carrier to Address Poor Bioavailability Issue of Raloxifene Hydrochloride |
2012 - 2013 | Effects of Pluchea Indica on Glucose Uptake and Glucose Transportation (Glut 4) Gene Expression of Adipocyte Cells |
2012 - 2015 | Sintesis analog dan modifikasi struktur mitragynine untuk mengkaji perkaitan di antara stuktur mitragynine dengan kesan psikoaktif drug |
2011 - 2014 | Bio-equivalence Study of Generic Gliclazide Tablet (IIUM Pharmacy) and Brand-name Gliclazide Tablet (Diamicron)in Healthy Male Volunteers |
2010 - 2016 | Structure-Based Virtual Screening of Chemical Libraries and Functional Assay on Small-Cell Lung Cancer In Vivo Molecular Targets |
2010 - 2013 | Bioactivity-guided fractionation of Pluchea Indica (beluntas) extract by using RIN5f pancreatic ?-cell line |
2007 - 2010 | Study on Antidiabetic Effect and the Possible Mechanism of Action of Pithecellobium Jiringa (Jering) |
2006 - 2008 | Nanoemulsion of Palm Olein for Drug Delivery |
On-Going
2021 - Present | Investigation on the Use of Sarawak Native Plant, Engkala Bark in Neurodegenerative Disease |
2007 - Present | Advanced Delivery System Using Locally - Produces Implantable Antibiotics- Incorporated Apatite Beads For Bone Repair -BioDDS |
Publications
Article
Conference or Workshop Item
Book Section
2011 | Research and development on antidiabetic herbs : Malaysia perspective. In: IIUM Press, ISBN: 9789674180195, pp. 227-237 |